Skip Navigation


NDT Advance Access originally published online on October 18, 2006
Nephrology Dialysis Transplantation 2007 22(2):668-669; doi:10.1093/ndt/gfl575
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/2/668    most recent
gfl575v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sobkowicz, B.
Right arrow Articles by Musial, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sobkowicz, B.
Right arrow Articles by Musial, W. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Value of the real-time myocardial contrast echocardiography for risk stratification and for the detection of significant coronary stenosis in patients with end-stage renal disease

Email: sobkowic@wp.pl

The first 10% of the full text of this article appears below.

Sir,

Coronary artery disease (CAD) is common in patients with end-stage renal disease (ESRD), and is associated with poor clinical outcome. However, routine screening for CAD in asymptomatic ESRD patients is usually not required, except for renal transplant candidates [1]. Myocardial contrast echocardiography (MCE) is a new bedside technique providing information regarding myocardial tissue perfusion. The assumption that MCE might be useful in patients with ESRD has not been previously investigated. Moreover, there are no published data concerning prognostic utility of MCE in patients with ESRD.

The aim of the study was to assess the prognostic significance of MCE in patients with ESRD, and to . . . [Full Text of this Article]

Bozena Sobkowicz1, Anna Tomaszuk-Kazberuk1, Jolanta Malyszko2, Marek Kalinowski2, Tomasz Hryszko2, Pawel Kralisz3, Slawomir Dobrzycki3, Jacek Malyszko2, Michal Mysliwiec2 and Wlodzimierz J. Musial1

1Department of Cardiology
2Department of Nephrology
3Department of Invasive Cardiology
Medical University
Bialystok
Poland


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
B. Sobkowicz, A. Tomaszuk-Kazberuk, P. Kralisz, J. Malyszko, M. Kalinowski, T. Hryszko, R. Sawicki, S. Dobrzycki, and W. J. Musial
Coronary blood flow in patients with end-stage renal disease assessed by thrombolysis in myocardial infarction frame count method
Nephrol. Dial. Transplant., October 28, 2009; (2009) gfp533v1.
[Abstract] [Full Text] [PDF]